Proprietary Oncology Asset(s)

About Selvita

Selvita is a mission-driven biotech bridging scientific innovation and clinical development through a dual model of integrated CRO services and proprietary drug R&D. Founded in 2007 and publicly listed in Warsaw, the company has matured into a Central European leader, leveraging its scientific platform to generate service revenue and build value in its oncology pipeline. Its strategy focuses on operational excellence in its service division to fund and de-risk the advancement of its internal therapeutic candidates, targeting significant unmet medical needs in cancer.

About Selvita

Selvita is a mission-driven biotech bridging scientific innovation and clinical development through a dual model of integrated CRO services and proprietary drug R&D. Founded in 2007 and publicly listed in Warsaw, the company has matured into a Central European leader, leveraging its scientific platform to generate service revenue and build value in its oncology pipeline. Its strategy focuses on operational excellence in its service division to fund and de-risk the advancement of its internal therapeutic candidates, targeting significant unmet medical needs in cancer.

Therapeutic Areas